ASH 2011: Daniel Heintel - High Expression of the Thalidomide-Binding Protein Cereblon (CRBN) Is Associated with Improved Clinical Response in Patients with Multiple Myeloma Treated with Lenalidomide and Dexamethasone
Daniel Heintel
Wilhelminenhospital
Vienna, Austria
12.06.11
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
button next to the volume control in the
lower right hand corner.
print
related articles